Page last updated: 2024-09-04

cinacalcet and Hyperparathyroidism, Primary

cinacalcet has been researched along with Hyperparathyroidism, Primary in 95 studies

Research

Studies (95)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	30 (31.58)	29.6817
2010's	46 (48.42)	24.3611
2020's	19 (20.00)	2.80

Authors

Authors	Studies
Kim, SJ; Shoback, DM	1
Bilezikian, JP; Chandran, M; Lau, J; Parameswaran, R; Rajeev, R; Samuel, M; Yang, SP	1
Capuano, B; Conigrave, AD; Dinh, LV; Gregory, KJ; Josephs, TM; Keller, AN; Leach, K; Zhang, F	1
Demir, S; Dilek, E; Gürkan, H; İnan, M; Kökenli, F; Özgüç Çömlek, F; Sezer, A	1
Bibik, E; Dobreva, E; Eremkina, A; Gorbacheva, A; Krupinova, J; Mirnaya, S; Mokrysheva, N	1
Bakaa, L; Bilezikian, JP; Brandi, ML; Chang, Y; Clarke, B; Couban, RJ; Guyatt, G; Khan, AA; Manja, V; Mannstadt, M; Silverberg, SJ; Sreekanta, A; Tangamornsuksun, W; Tong, K; Wang, Y; Ye, Z; Zhang, M; Zhang, Y	1
Brown, JM; Heydarpour, M; Mannstadt, M; Parksook, WW; Turchin, A; Vaidya, A	1
Bandeira, F; Bilezikian, J; de Moura Nóbrega, J; de Oliveira, LB	1
Dejkhamron, P; Intachai, W; Kantaputra, P; Ketudat Cairns, JR; Khorana, J; Ngamphiw, C; Olsen, B; Tongsima, S; Watcharachan, K; Wejaphikul, K	1
Ahmad, HM; Shafiq, MU; Shaukat, M	1
Bostanci, H; Göbüt, H	1
Bränström, R; Koman, A; Nilsson, IL; Ohlsson, S; Pernow, Y	1
Bottoni, G; Foppiani, L; Piccardo, A	1
Aschenbach, R; Biermann, A; Freesmeyer, M; Kloos, C; Lupp, A; Mtuka-Pardon, G; Seifert, P; Werner, C; Wolf, G	1
Cipriani, C; Minisola, S; Pepe, J	1
Brøndum Frøkjær, J; Handberg, A; Karmisholt, J; Leere, JS; Lykkeboe, S; Robaczyk, M; Steinkohl, E; Vestergaard, P	1
Ata, P; Bereket, A; Bilgen, H; Eltan, M; Gulcan-Kersin, S; Kirkgoz, T; Ozek, E; Rzayev, T; Turan, S	1
Abe, I; Kawanami, D; Kobayashi, K; Kudo, T; Minezaki, M; Mitsuoka, R; Ochi, K; Takashi, Y; Yamao, Y	1
Bränström, R; Koman, A; Nilsson, IL; Pernow, Y	1
Alfadhli, EM	1
Bailey, M; Manners, R; McDougall, C; Timmons, JG	1
Misiorowski, W; Zgliczyński, W	1
García-Martín, A; Muñoz-Torres, M	1
Carda, S; Da Costa F de Frias Pinto, A; Grana, E	1
Cetani, F; Ferrari, F; Marcocci, C	1
Accadia, M; Capozza, M; Chinellato, I; Di Lorgi, N; Di Mauro, A; Guarnieri, V; Laforgia, N; Mattioli, G; Traggiai, C	1
Huang, L; Sun, X; Tao, Y; Wu, J; Yang, F	1
Criseno, S; Gittoes, NJL; Hassan-Smith, ZK	1
Cetani, F; Marcocci, C; Saponaro, F	1
Fujita, M; Iiri, T; Ito, N; Kinoshita, Y; Makita, N; Manaka, K; Nangaku, M; Sato, J	1
Domínguez Quintero, ML; Ferrer Castillo, MT; García Soblechero, E; González Fuentes, C; Jiménez Crespo, B	1
Ogrin, C	1
Carratù, AC; Colao, A; De Luca Di Roseto, C; Del Prete, M; Di Sarno, A; Di Somma, C; Esposito, R; Faggiano, A; Marciello, F; Marotta, V; Ramundo, V	1
Buonomano, P; Circelli, L; Colao, A; Del Prete, M; Di Somma, C; Faggiano, A; Marciello, F; Marotta, V; Modica, R; Ramundo, V; Rubino, M; Sciammarella, C; Vitale, M	1
Body, JJ; Cáp, J; Farouk, M; Gessl, A; Hofbauer, LC; Kuhn, JM; Marcocci, C; Mattin, C; Muñoz Torres, M; Payer, J; Schwarz, P; Selby, P; Van De Ven, A; Yavropoulou, M	1
Dochez, V; Ducarme, G	1
Crouzeix, G; Kerlan, V	1
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C	1
Basuyau, JP; Cailleux, A; Kuhn, JM; Lefebvre, H; Ménard, JF; Prévost, G; Vuillermet, P	1
Brardi, S; Cevenini, G; Ponchietti, R; Romano, G; Verdacchi, T	1
Meier, C	1
Brandi, ML; Cianferotti, L; Cioppi, F; Colao, A; Faggiano, A; Ferolla, P; Giusti, F; Gronchi, G; Masi, L	1
Chauhan, P; Geberhiwot, T; Gittoes, NJ	1
Katagiri, M; Miura, D; Nakashima, N; Ohishi, H; Shimazaki, R; Takahashi, S; Takeuchi, Y; Tominaga, Y	1
Bentivoglio, G; Di Iorgi, N; Giusti, M; Oddo, S; Vera, L	1
Okada, A; Takeda, T; Tozawa, K; Umemoto, Y; Unno, R; Yasui, T	1
Akinci, B; Comlekci, A; Tankurt, E	1
Hallfeldt, K; Khalil, PN	1
Grey, A; Khan, A; Shoback, D	1
Bilezikian, J; Chanson, P; Cheng, S; Fernandez-Cruz, L; Henzen, C; Lu, J; Marcocci, C; Orgiazzi, J; Peacock, M; Shoback, D; Sterling, LR	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
García Martín, A; Muñoz Torres, M	1
Mosekilde, L; Vestergaard, P	1
de Boer, H; Groot, I; Hermus, A; Horjus, C; Kovacs, CS; Telting, D; van Setten, P; van Sorge, A	1
Shaw, NJ; Stanley, S	1
Padmanabhan, H	1
Abdellatif, A; Fanari, Z; Haque, W; Kadikoy, H; Pacha, O	1
Dillon, ML; Frazee, LA	1
Bilezikian, JP; Bolognese, MA; Borofsky, M; Cheng, S; Peacock, M; Scumpia, S; Shoback, D; Sterling, LR	1
Arranz Martín, A; Azcárate Villalón, A; Carraro, R; Gómez Pan, A; Luque Ramírez, M; Marazuela Azpíroz, M; Paniagua Ruiz, A; Santana Durán, B	1
Alfieri, C; Brezzi, B; Messa, P	1
Duntas, LH; Stathatos, N	1
Colao, A; Coppola, A; Di Somma, C; Faggiano, A; Gasperi, M; Lombardi, G; Panico, F; Ramundo, V; Savastano, S; Severino, R; Vuolo, L	1
Arnold, A; Imanishi, Y; Inaba, M; Kawata, T; Kenko, T; Miki, T; Nagano, N; Wada, M	1
Casanueva, FF; García López, JM; García Vázquez, M; Prieto Tenreiro, AM; Puñal Rodríguez, JA	1
Lopez, J; Norman, J; Politz, D	1
Banti, C; Cetani, F; Chiavistelli, S; Cianferotti, L; Marcocci, C; Pinchera, A; Saponaro, F; Viccica, G; Vignali, E	1
Cetani, F; Marcocci, C	1
Abreu, C; Castro, JC; Díez, JJ; Iglesias, P	1
Jacobs, L; Koek, HL; Samson, MM; Verhaar, HJ	1
Girardin, E; Magdelaine, C; Parvex, P; Wilhelm-Bals, A	1
Beck-Peccoz, P; Corbetta, S; Eller-Vainicher, C; Ermetici, F; Filopanti, M; Olgiati, L; Persani, L; Spada, A; Verga, U	1
McCaffrey, P; Wallace, HJ; Wallace, IR	1
Banti, C; Borretta, G; Brandi, ML; Cavalli, L; Cetani, F; Colao, A; Del Prete, M; Faggiano, A; Frasoldati, A; Gianotti, L; Grimaldi, F; Marcocci, C; Minisola, S; Papini, E; Romagnoli, E; Saponaro, F; Scillitani, A; Vescini, F	1
Nagano, N	1
de Vernejoul, MC; Legoupil, N; Ureña, P	1
Dong, BJ	1
Mosekilde, L; Nielsen, LR; Vestergaard, P	1
Fottner, C; Weber, MM	1
Imanishi, Y; Inaba, M; Ishikawa, T; Ishimura, E; Kawata, T; Kobayashi, K; Komo, T; Miki, T; Nagano, N; Nishizawa, Y; Okuno, S; Onoda, N; Tahara, H; Takemoto, Y; Wada, M	1
Szmuilowicz, ED; Utiger, RD	1
Choukroun, G; Fournier, A; Massy, Z; Mazouz, H; Monge, M; Morinière, P; Oprisiu, R; Shahapuni, I; Westeel, PF	1
Bilezikian, JP; Silverberg, SJ	1
Bruns, DE; D'Amour, P; Hanks, JB; Henrich, LM; Levine, MA; Rogol, AD	1
Angelos, P; Sturgeon, C; Zanocco, K	1
Fukagawa, M; Nakanishi, S	1
Prié, D	1
Farford, B; Moraghan, TJ; Presutti, RJ	1
Bilezikian, JP; Brossard, JH; Cantor, T; D'Amour, P; Rousseau, L; Rubin, MR; Silverberg, SJ; Sliney, J	1
Bilezikian, JP; Faiman, C; Klassen, P; Olson, KA; Peacock, M; Rubin, MR; Schwanauer, LE; Shoback, DM; Silverberg, SJ; Smallridge, RC	1
Bilezikian, JP; Martin, D; Wüthrich, RP	1
Ais, G; Díez, JJ; Fernández Pardo, E; García Arévalo, C; González, A; Iglesias, P; Tajada, P	1
Hershman, JM; Sajid-Crockett, S; Singer, FR	1
de Francisco, AL	1
Amedei, A; Brandi, ML; Cilotti, A; Cioppi, F; Falchetti, A; Masi, L; Tonelli, F; Vagelli, L; Vaggelli, L	1

Reviews

33 review(s) available for cinacalcet and Hyperparathyroidism, Primary

Article	Year
Sporadic Primary Hyperparathyroidism. Endocrinology and metabolism clinics of North America, 2021, Volume: 50, Issue:4 Topics: Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Male	2021
The efficacy and safety of cinacalcet in primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials and cohort studies. Reviews in endocrine & metabolic disorders, 2022, Volume: 23, Issue:3 Topics: Cinacalcet; Humans; Hyperparathyroidism, Primary; Randomized Controlled Trials as Topic	2022
Different treatment strategies in primary hyperparathyroidism during pregnancy. Endocrine, 2022, Volume: 77, Issue:3 Topics: Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Parathyroidectomy; Pregnancy; Pregnancy Complications	2022
The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2022, Volume: 37, Issue:11 Topics: Alendronate; Calcium; Cinacalcet; Denosumab; Estrogens; Humans; Hyperparathyroidism, Primary; Parathyroid Hormone; Quality of Life; Randomized Controlled Trials as Topic; Vitamin D	2022
Medical management of primary hyperparathyroidism. Archives of endocrinology and metabolism, 2022, Nov-11, Volume: 66, Issue:5 Topics: Cinacalcet; Humans; Hyperparathyroidism, Primary; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy	2022
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic. Clinical therapeutics, 2021, Volume: 43, Issue:4 Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D	2021
Primary hyperparathyroidism. Medicina clinica, 2018, 03-23, Volume: 150, Issue:6 Topics: Biomarkers; Calcium; Calcium-Regulating Hormones and Agents; Cinacalcet; Diagnosis, Differential; Humans; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy	2018
Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review. Medicine, 2018, Volume: 97, Issue:45 Topics: Calcimimetic Agents; Calcium; Cinacalcet; Female; Genetic Testing; Homozygote; Humans; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroid Hormone; Receptors, Calcium-Sensing	2018
Mild primary hyperparathyroidism-to treat or not to treat? British medical bulletin, 2019, 03-01, Volume: 129, Issue:1 Topics: Bone Density; Calcium-Regulating Hormones and Agents; Cardiovascular Diseases; Cinacalcet; Clinical Decision-Making; Humans; Hyperparathyroidism, Primary; Neoplasms; Nephrolithiasis; Parathyroidectomy; Quality of Life	2019
Non-surgical management of primary hyperparathyroidism. Best practice & research. Clinical endocrinology & metabolism, 2018, Volume: 32, Issue:6 Topics: Calcium; Cinacalcet; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Pregnancy; Pregnancy Complications; Vitamin D Deficiency	2018
Primary hyperparathyroidism during pregnancy. Archives of gynecology and obstetrics, 2015, Volume: 291, Issue:2 Topics: Calcitonin; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperplasia; Naphthalenes; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications	2015
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. BMC endocrine disorders, 2015, Jan-28, Volume: 15 Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid	2015
Benefits and place of calcimimetics in the management of primary hyperparathyroidism. Annales d'endocrinologie, 2015, Volume: 76, Issue:2 Topics: Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Primary; Parathyroid Glands; Parathyroidectomy	2015
Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. Journal of medical case reports, 2016, Dec-20, Volume: 10, Issue:1 Topics: Adult; Calcimimetic Agents; Cesarean Section; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Hypodermoclysis; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Treatment Outcome	2016
[Diagnosis and therapy of primary hyperparathyreoidism]. MMW Fortschritte der Medizin, 2008, Nov-06, Volume: 150, Issue:45 Topics: Adenoma; Adult; Bone Density Conservation Agents; Calcium; Cinacalcet; Diagnosis, Differential; Diphosphonates; Diuretics; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Incidence; Minimally Invasive Surgical Procedures; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Prevalence; Sex Factors; Video-Assisted Surgery	2008
Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:2 Topics: Bone Density Conservation Agents; Bone Diseases; Calcium; Cinacalcet; Consensus; Cost-Benefit Analysis; Diphosphonates; Hormone Replacement Therapy; Humans; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone; Patient Selection; Treatment Outcome	2009
Medical management of primary hyperparathyroidism with concomitant multiple myeloma. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:6 Topics: Cinacalcet; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Multiple Myeloma; Naphthalenes; Pancytopenia; Treatment Outcome	2010
Cinacalcet for the treatment of primary hyperparathyroidism. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Bone Density; Bone Density Conservation Agents; Calcimimetic Agents; Calcitonin; Cinacalcet; Diphosphonates; Estrogen Replacement Therapy; Estrogens; Female; Humans; Hyperparathyroidism, Primary; Naphthalenes; Osteoporosis; Raloxifene Hydrochloride	2011
Clinical utilization of cinacalcet in hypercalcemic conditions. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:4 Topics: Calcimimetic Agents; Cinacalcet; Clinical Trials as Topic; Drug Evaluation; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Receptors, Calcium-Sensing; Renal Dialysis	2011
Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects. Endocrine, 2011, Volume: 39, Issue:3 Topics: Calcimimetic Agents; Cinacalcet; Contraindications; Diphosphonates; Endocrine Surgical Procedures; Humans; Hyperparathyroidism, Primary; Naphthalenes; Selective Estrogen Receptor Modulators	2011
Update on the use of cinacalcet in the management of primary hyperparathyroidism. Journal of endocrinological investigation, 2012, Volume: 35, Issue:1 Topics: Cinacalcet; Disease Management; Humans; Hyperparathyroidism, Primary; Naphthalenes	2012
Pharmacological and clinical properties of calcimimetics: calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacology & therapeutics, 2006, Volume: 109, Issue:3 Topics: Aniline Compounds; Animals; Calcium; Cinacalcet; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Phenethylamines; Propylamines; Receptors, Calcium-Sensing	2006
[Calcimimetics, mechanisms of action and therapeutic applications]. Presse medicale (Paris, France : 1983), 2005, Sep-10, Volume: 34, Issue:15 Topics: Aniline Compounds; Animals; Bone Remodeling; Calcium; Cells, Cultured; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic; Rats; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Time Factors; Uremia	2005
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Clinical therapeutics, 2005, Volume: 27, Issue:11 Topics: Animals; Area Under Curve; Calcium; Cinacalcet; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Interactions; Half-Life; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis	2005
[Cinacalcet--a new drug for the treatment of secondary hyperparathyroidism in patients with uraemia, parathyroid cancer or primary hyperparathyroidism]. Ugeskrift for laeger, 2006, Jan-03, Volume: 168, Issue:1 Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing; Uremia	2006
[The latest developments in endocrinology 2004/2005]. Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1 Topics: Adrenal Gland Neoplasms; Adult; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Clinical Trials as Topic; Endocrinology; Eplerenone; Female; Humans; Hyperaldosteronism; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hypogonadism; Hypothyroidism; Male; Naphthalenes; Neuroendocrine Tumors; Organometallic Compounds; Osteoporosis, Postmenopausal; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiography, Abdominal; Spironolactone; Teriparatide; Testosterone; Testosterone Congeners; Thiophenes; Time Factors; Tomography, X-Ray Computed	2006
Drug Insight: renal indications of calcimimetics. Nature clinical practice. Nephrology, 2006, Volume: 2, Issue:6 Topics: Calcium; Cinacalcet; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Naphthalenes; Parathyroid Neoplasms; Renal Dialysis	2006
The diagnosis and management of asymptomatic primary hyperparathyroidism. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:9 Topics: Bone Diseases; Cardiovascular Diseases; Cinacalcet; Diphosphonates; Estrogens; Gastrointestinal Diseases; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Glands; Phosphates; Renal Insufficiency	2006
[Therapeutic agents for disorders of bone and calcium metabolism. The calcimimetic cinacalcet HCl]. Clinical calcium, 2007, Volume: 17, Issue:1 Topics: Cinacalcet; Clinical Trials as Topic; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Kidney Transplantation; Mutation; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Receptors, Calcium-Sensing	2007
[Hypercalcemia (with treatment)]. La Revue du praticien, 2006, Oct-31, Volume: 56, Issue:16 Topics: Adrenal Cortex Hormones; Aged; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcitriol; Calcium; Cinacalcet; Creatinine; Densitometry; Diphosphonates; Emergencies; Female; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Mutation; Naphthalenes; Parathyroid Hormone; Radionuclide Imaging; Receptors, Calcium-Sensing; Renal Insufficiency; Thyroid Hormones	2006
Nonsurgical management of primary hyperparathyroidism. Mayo Clinic proceedings, 2007, Volume: 82, Issue:3 Topics: Cinacalcet; Diet; Diphosphonates; Estrogen Replacement Therapy; Humans; Hyperparathyroidism, Primary; Life Style; Naphthalenes; Raloxifene Hydrochloride; Sclerotherapy; Selective Estrogen Receptor Modulators	2007
The role of calcimimetics in the treatment of hyperparathyroidism. European journal of clinical investigation, 2007, Volume: 37, Issue:12 Topics: Adenoma; Calcium; Cinacalcet; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy	2007
New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:5 Topics: Animals; Calcium; Cinacalcet; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Renal Insufficiency	2008

Trials

9 trial(s) available for cinacalcet and Hyperparathyroidism, Primary

Article	Year
Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo-controlled randomized trial. Clinical endocrinology, 2023, Volume: 98, Issue:4 Topics: Aldosterone; Amiloride; Calcium; Cinacalcet; Eplerenone; Female; Humans; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Renin	2023
Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial. The lancet. Diabetes & endocrinology, 2020, Volume: 8, Issue:5 Topics: Aged; Bone Density; Bone Remodeling; Cinacalcet; Denosumab; Double-Blind Method; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged	2020
Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2015, Mar-31, Volume: 87, Issue:1 Topics: Aged; Allopurinol; Calcimimetic Agents; Cinacalcet; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nephrolithiasis; Pilot Projects; Potassium Citrate; Prospective Studies; Treatment Outcome	2015
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1). Endocrine, 2016, Volume: 52, Issue:3 Topics: Adenoma; Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Longitudinal Studies; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Young Adult	2016
Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism. Journal of bone and mineral metabolism, 2017, Volume: 35, Issue:6 Topics: Adult; Aged; Asian People; Calcium; Calcium, Dietary; Cinacalcet; Creatinine; Demography; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Vital Signs	2017
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:1 Topics: Absorptiometry, Photon; Alkaline Phosphatase; Analysis of Variance; Bone Density; Calcium; Cinacalcet; Double-Blind Method; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphates; Severity of Illness Index; Treatment Outcome	2011
[Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Asthenia; Calcium; Cinacalcet; Contraindications; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nausea; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Prospective Studies; Vitamin D	2011
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly. European journal of endocrinology, 2012, Volume: 167, Issue:2 Topics: Adenoma; Adult; Amino Acid Substitution; Arginine; Calcimimetic Agents; Cinacalcet; Cross-Over Studies; Double-Blind Method; Female; Glycine; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroid Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Receptors, Calcium-Sensing; Treatment Outcome; Young Adult	2012
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:10 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Quality of Life; Treatment Outcome	2007

Other Studies

53 other study(ies) available for cinacalcet and Hyperparathyroidism, Primary

Article	Year
Personalised medicines for familial hypercalcemia and hyperparathyroidism. Journal of molecular endocrinology, 2022, 05-09, Volume: 69, Issue:1 Topics: Calcium; Cinacalcet; HEK293 Cells; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Mutation; Precision Medicine; Receptors, Calcium-Sensing	2022
The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene. Pediatric endocrinology, diabetes, and metabolism, 2022, Volume: 28, Issue:2 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing	2022
Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation. Hormone research in paediatrics, 2023, Volume: 96, Issue:4 Topics: Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hypoparathyroidism; Infant; Infant, Newborn; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing	2023
Neonatal severe hyperparathyroidism: A case report. JPMA. The Journal of the Pakistan Medical Association, 2022, Volume: 72, Issue:12 Topics: Calcium; Child; Cinacalcet; Heterozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Mutation	2022
The evolution of primary hyperparathyroidism publications and global productivity from past to present: A bibliometric analysis during 1980 to 2022. Medicine, 2023, Sep-01, Volume: 102, Issue:35 Topics: Bibliometrics; Child; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Positron Emission Tomography Computed Tomography; Pregnancy; Quality of Life	2023
Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy. The British journal of surgery, 2019, Volume: 106, Issue:13 Topics: Aged; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroidectomy; Pilot Projects; Postoperative Period; Quality of Life; Treatment Outcome	2019
Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics. Acta medica (Hradec Kralove), 2019, Volume: 62, Issue:4 Topics: Aged, 80 and over; Calcimimetic Agents; Choline; Cinacalcet; Fluorine Radioisotopes; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Severity of Illness Index	2019
Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet. BMC endocrine disorders, 2020, Apr-20, Volume: 20, Issue:1 Topics: Adenoma; Biopsy; Calcium-Regulating Hormones and Agents; Cinacalcet; Cysts; Diagnostic Errors; Disease Progression; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Thyroid Diseases; Tumor Burden; Ultrasonography	2020
Skeletal protection in patients with primary hyperparathyroidism. The lancet. Diabetes & endocrinology, 2020, Volume: 8, Issue:5 Topics: Bone Diseases; Cinacalcet; Denosumab; Double-Blind Method; Humans; Hyperparathyroidism, Primary	2020
Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation. Hormone research in paediatrics, 2020, Volume: 93, Issue:5 Topics: Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Receptors, Calcium-Sensing	2020
Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism. Journal of bone and mineral metabolism, 2021, Volume: 39, Issue:4 Topics: Adenoma; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Tumor Burden; Ultrasonography	2021
Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism. BJS open, 2021, 03-05, Volume: 5, Issue:2 Topics: Adult; Aged; Calcimimetic Agents; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroidectomy; Prospective Studies; Treatment Outcome	2021
Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism. Hormones (Athens, Greece), 2021, Volume: 20, Issue:3 Topics: Aged; Calcium; Cinacalcet; Cognitive Dysfunction; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes; Parathyroid Hormone	2021
Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery. Endokrynologia Polska, 2017, Volume: 68, Issue:3 Topics: Adult; Aged; Calcimimetic Agents; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Parathyroid Hormone	2017
Acute pseudogout after cinacalcet treatment. Kidney international, 2018, Volume: 94, Issue:4 Topics: Acute Disease; Aged, 80 and over; Calcimimetic Agents; Calcium; Chondrocalcinosis; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary	2018
Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up. Journal of endocrinological investigation, 2019, Volume: 42, Issue:2 Topics: Calcium-Regulating Hormones and Agents; Cinacalcet; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Remission, Spontaneous; Renal Dialysis; Severity of Illness Index; Treatment Outcome	2019
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. BMC pediatrics, 2018, 10-30, Volume: 18, Issue:1 Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; Female; Fluid Therapy; Furosemide; Genes, Recessive; Homozygote; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Parathyroidectomy; Receptors, Calcium-Sensing	2018
Effectiveness and safety of cinacalcet for primary hyperparathyroidism: a single center experience. Endocrine journal, 2019, Aug-29, Volume: 66, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Middle Aged; Nausea; Retrospective Studies; Treatment Outcome	2019
Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet. Neonatology, 2013, Volume: 104, Issue:2 Topics: Calcimimetic Agents; Cinacalcet; DNA Mutational Analysis; Drug Resistance; Exons; Genetic Predisposition to Disease; Homozygote; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Infant, Newborn, Diseases; Male; Naphthalenes; Phenotype; Receptors, Calcium-Sensing; Sequence Deletion; Treatment Failure	2013
Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism. Minerva endocrinologica, 2013, Volume: 38, Issue:3 Topics: Alkaline Phosphatase; Bone Density; Calcium; Cinacalcet; Diphosphonates; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Ibandronic Acid; Naphthalenes; Osteoporosis; Parathyroid Hormone; Phosphates; Vitamin D	2013
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1. Minerva endocrinologica, 2013, Volume: 38, Issue:4 Topics: Adult; Biomarkers; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Middle Aged; Mothers; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Nuclear Family; Parathyroid Hormone; Pedigree; Phosphorus; Treatment Outcome	2013
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication. Endocrine, 2015, Volume: 49, Issue:1 Topics: Adult; Bone Density; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Parathyroid Hormone; Treatment Outcome	2015
The PRIMARA study: a prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice. European journal of endocrinology, 2014, Volume: 171, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cinacalcet; Dose-Response Relationship, Drug; Europe; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Practice Patterns, Physicians'; Retrospective Studies; Young Adult	2014
[Primary hyperparathyroidism: new concepts, new recommendations]. Annales d'endocrinologie, 2014, Volume: 75 Suppl 1 Topics: Adult; Aged; Bone Density; Calcium; Cinacalcet; Diphosphonates; Endocrinology; Fractures, Bone; General Surgery; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant; Infant, Newborn; Lithiasis; Middle Aged; Naphthalenes; Nephrocalcinosis; Practice Guidelines as Topic; Risk Factors; Societies, Medical; Vitamin D Deficiency	2014
A step towards cinacalcet testing for the diagnosis of primary hyperparathyroidism: comparison with the standardized intravenous calcium loading. A pilot study. Clinical endocrinology, 2015, Volume: 82, Issue:5 Topics: Administration, Oral; Adult; Calcium; Calcium Gluconate; Cinacalcet; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Primary; Infusions, Intravenous; Male; Middle Aged; Parathyroid Hormone; Pilot Projects; Random Allocation; Time Factors; Treatment Outcome	2015
Successful treatment of recurrent renal stones with Cinacalcet in a patient with primary hyperparathyroidism. BMJ case reports, 2016, Aug-12, Volume: 2016 Topics: Aged; Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Primary; Kidney Calculi; Male; Recurrence; Treatment Outcome	2016
[A Case of Primary Hyperparathyroidism Complicated with Hypercalcemic Crisis during Treatment with Cinacalcet and Improved by Active Treatment]. Hinyokika kiyo. Acta urologica Japonica, 2016, Volume: 62, Issue:12 Topics: Aged; Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Primary; Male; Tomography, X-Ray Computed; Treatment Outcome	2016
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2009, Volume: 117, Issue:3 Topics: Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Cirrhosis; Middle Aged; Naphthalenes; Parathyroid Neoplasms; Ultrasonography	2009
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:8 Topics: Aged; Aged, 80 and over; Calcium; Cinacalcet; Female; Health Status; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Quality of Life	2009
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
[Medical treatment of primary hyperparathyroidism: role of calcimimetics]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56 Suppl 1 Topics: Calcimimetic Agents; Cinacalcet; Humans; Hyperparathyroidism, Primary; Naphthalenes	2009
[Medical treatment of patients with primary hyperparathyroidism]. Ugeskrift for laeger, 2009, Aug-10, Volume: 171, Issue:33 Topics: Bone Density Conservation Agents; Calcium; Cinacalcet; Diphosphonates; Humans; Hyperparathyroidism, Primary; Naphthalenes	2009
Cinacalcet for hyperparathyroidism in pregnancy and puerperium. Journal of pediatric endocrinology & metabolism : JPEM, 2009, Volume: 22, Issue:8 Topics: Adult; Calcitonin; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Infant, Newborn; Male; Naphthalenes; Postpartum Period; Pregnancy; Pregnancy Complications; Treatment Outcome	2009
Is it my calcium, Doctor? Archives of disease in childhood. Education and practice edition, 2009, Volume: 94, Issue:6 Topics: Calcium; Child; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Kidney Calculi; Naphthalenes; Parathyroid Hormone; Renal Colic; Ultrasonography	2009
Cinacalcet in the treatment of intractable hypercalcemia following two neck exploration surgeries for primary hyperparathyroidism. Southern medical journal, 2010, Volume: 103, Issue:3 Topics: Aged, 80 and over; Biomimetic Materials; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Neoplasms; Receptors, Calcium-Sensing	2010
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism. Endocrine, 2011, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Alendronate; Bone Density; Bone Density Conservation Agents; Calcium; Cinacalcet; Drug Therapy, Combination; Female; Femur; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Lumbar Vertebrae; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Retrospective Studies	2011
Cinacalcet HCl suppresses Cyclin D1 oncogene-derived parathyroid cell proliferation in a murine model for primary hyperparathyroidism. Calcified tissue international, 2011, Volume: 89, Issue:1 Topics: Animals; Apoptosis; Cell Proliferation; Cinacalcet; Cyclin D1; Hyperparathyroidism, Primary; Mice; Mice, Transgenic; Models, Animal; Naphthalenes; Oncogenes; Parathyroid Glands; Parathyroid Hormone	2011
[The value of selective parathyroid venous sampling for localizing occult parathyroid adenomas]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1 Topics: Adenoma; Aged; Blood Specimen Collection; Catheterization, Peripheral; Cinacalcet; False Negative Reactions; Female; Goiter, Nodular; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Magnetic Resonance Imaging; Naphthalenes; Neoplasm Recurrence, Local; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Preoperative Care; Radionuclide Imaging; Reoperation; Thyroidectomy; Veins; Vitamin D Deficiency	2012
Cinacalcet (Sensipar) provides no measurable clinical benefits for patients with primary hyperparathyroidism and may accelerate bone loss with prolonged use. Annals of surgical oncology, 2012, Volume: 19, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Density; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Nausea; Osteoporosis; Treatment Failure; Vomiting; Young Adult	2012
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. Journal of endocrinological investigation, 2012, Volume: 35, Issue:7 Topics: Aged; Aged, 80 and over; Biomarkers; Cinacalcet; Contraindications; Drug Labeling; European Union; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Maintenance Chemotherapy; Membrane Transport Modulators; Middle Aged; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroidectomy; Practice Guidelines as Topic; Prospective Studies; Receptors, Calcium-Sensing; Severity of Illness Index	2012
[Long-term combined treatment with cinacalcet and bisphosphonates in persistent primary hyperparathyroidism after surgery]. Medicina clinica, 2012, May-26, Volume: 138, Issue:15 Topics: Alendronate; Bone Density Conservation Agents; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hypercalciuria; Hyperparathyroidism, Primary; Hyperphosphatemia; Middle Aged; Naphthalenes; Osteoporosis; Postoperative Complications	2012
Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism. The Netherlands journal of medicine, 2012, Volume: 70, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Calcimimetic Agents; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes	2012
Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics, 2012, Volume: 129, Issue:3 Topics: Calcium; Cinacalcet; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Follow-Up Studies; Humans; Hyperparathyroidism, Primary; Infant, Newborn; Magnetic Resonance Imaging; Male; Naphthalenes; Parathyroidectomy; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Cognitive decline reversed by cinacalcet. QJM : monthly journal of the Association of Physicians, 2015, Volume: 108, Issue:1 Topics: Aged, 80 and over; Calcimimetic Agents; Cinacalcet; Cognition Disorders; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Naphthalenes	2015
Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group. Clinical endocrinology, 2013, Volume: 79, Issue:1 Topics: Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Hyperparathyroidism, Primary; Hypocalcemia; Italy; Male; Middle Aged; Naphthalenes; Parathyroidectomy; Product Surveillance, Postmarketing; Retrospective Studies; Time Factors; Treatment Outcome	2013
Direct in vitro evidence of the suppressive effect of cinacalcet HCl on parathyroid hormone secretion in human parathyroid cells with pathologically reduced calcium-sensing receptor levels. Journal of bone and mineral metabolism, 2006, Volume: 24, Issue:4 Topics: Cinacalcet; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Immunohistochemistry; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Receptors, Calcitriol; Receptors, Calcium-Sensing	2006
A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:5 Topics: Adenocarcinoma; Alcohol Drinking; Biopsy, Fine-Needle; Calcitriol; Calcium; Cinacalcet; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Liver Neoplasms; Male; Middle Aged; Naphthalenes; Neck; Neoplasm Metastasis; Parathyroid Hormone; Parathyroid Neoplasms; Radiography; Ultrasonography	2006
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl. Clinical chemistry, 2006, Volume: 52, Issue:12 Topics: Adolescent; Calcium; Cinacalcet; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus	2006
Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery, 2006, Volume: 140, Issue:6 Topics: Cinacalcet; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Support Techniques; Health Care Costs; Humans; Hyperparathyroidism, Primary; Insurance, Health, Reimbursement; Length of Stay; Middle Aged; Minimally Invasive Surgical Procedures; Naphthalenes; Parathyroidectomy; Patient Selection; Quality-Adjusted Life Years	2006
An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma. Clinical chemistry, 2007, Volume: 53, Issue:8 Topics: Adult; Aged; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroid Neoplasms; Peptide Fragments	2007
Acute and one-year effects of cinacalcet in patients with persistent primary hyperparathyroidism after unsuccessful parathyroidectomy. The American journal of the medical sciences, 2008, Volume: 335, Issue:2 Topics: Adult; Aged; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Middle Aged; Naphthalenes; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Treatment Outcome	2008
Cinacalcet for the treatment of primary hyperparathyroidism. Metabolism: clinical and experimental, 2008, Volume: 57, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Retrospective Studies	2008
A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:6 Topics: Adult; Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Primary; Multiple Endocrine Neoplasia Type 1; Naphthalenes; Parathyroid Hormone	2008